CALL AN EXPERT! +86-131-3073-8426
Pharma Clean Room 2026: Annex 1, FDA & ISO Guide
A pharma clean room can meet its particle target and still fail a GMP inspection. Start with the process, build a contamination control strategy, and align design, qualification, monitoring, and operations before purchasing equipment. EU GMP Annex 1 has been fully applicable since August 25, 2024, making barrier technology, airflow visualization, and lifecycle control baseline expectations.
Translate Global Pharmaceutical Regulations into Design Requirements
Apply EU GMP Annex 1 Grades and the Contamination Control Strategy
Annex 1 uses Grades A–D, but each grade must match the operation and contamination risk. Grade A protects exposed sterile product; Grade B commonly supports Grade A; Grades C and D cover less critical stages. The contamination control strategy should connect facilities, personnel, utilities, cleaning, monitoring, maintenance, and process controls.
Grade | Typical role | ≥0.5 µm particles/m³ at rest | In operation |
A | Critical aseptic zone | 3,520 | 3,520 |
B | Grade A background | 3,520 | 352,000 |
C | Controlled preparation | 352,000 | 3,520,000 |
D | Early-stage support | 3,520,000 | Risk-based |
Annex 1 gives a 10 Pa guidance value between adjacent grades and 0.36–0.54 m/s for unidirectional airflow at the working position. These values do not replace smoke studies or process-specific justification.
Coordinate FDA CGMP, Aseptic Processing Guidance, WHO GMP, and ISO 14644
FDA’s aseptic-processing guidance supports 21 CFR Parts 210 and 211, identifies ISO 5/Class 100 conditions at exposed sterile operations, and recommends 10–15 Pa between different classifications. WHO’s 2022 sterile GMP text was harmonized with the EU and PIC/S. ISO 14644-1 classifies airborne particles; ISO 14644-3 provides test methods.
ISO certification alone is not pharmaceutical approval. A pharmacy clean room may instead be driven by USP <797> and, for hazardous drugs, USP <800>; those requirements should not be copied directly into an industrial sterile-drug facility.
Design the Facility Around the Pharmaceutical Process
Establish Pressure Cascades, Airlocks, Personnel Routes, and Material Flows
Map product exposure, sterilization, gowning, component transfer, waste, and maintenance access. From the projects we’ve completed, crossed personnel and material routes cause more late redesign than wall-panel selection. Separate entry and exit paths, interlock airlock doors, and keep waste downstream of clean material flow.
In our experience, pressure cascades work best when door behavior and exhaust loads are modeled early. A room may hold 15 Pa during an empty test yet lose control when a pass box, autoclave, or extraction system operates.
Integrate RABS, Isolators, Process Utilities, HVAC, and Monitoring Locations
RABS and isolators reduce operator influence, but add transfer-port qualification, glove testing, decontamination-cycle development, and maintenance constraints. Select monitoring locations from airflow studies and product risk, not a simple floor-area grid. Annex 1 specifically encourages barrier technologies where they improve product protection.
For concept budgeting, industry estimates place modular ISO 7 pharmaceutical space near $350–$650 per square foot, while Grade A/B suites may reach $500–$750+ before major process equipment. Modular cleanrooms can shorten installation and expansion, but poorly detailed joints, penetrations, and controls increase commissioning work. During cleanroom construction, treat these numbers as allowances because location, redundancy, utilities, and validation scope can move costs sharply.
Qualify and Maintain the Pharma Clean Room
Plan DQ, IQ, OQ, PQ, HEPA Integrity, Recovery, and Airflow Visualization Tests
The validation master plan should define the URS, risk assessments, DQ, IQ, OQ, PQ, traceability, acceptance criteria, deviations, and change control. Annex 1 expects classification, final-filter integrity, airflow volume, pressure verification, and velocity or recovery testing. EU GMP Annex 15 also requires lifecycle qualification based on justified and documented risk assessments.
Record airflow visualization at rest and in operation, including routine and worst-case interventions. Annex 1 sets maximum requalification intervals of six months for Grades A/B and 12 months for Grades C/D, plus retesting after significant HVAC, filter, facility, or process changes.
Manage Environmental Monitoring, Cleaning, Deviations, and Requalification
Build monitoring from the contamination control strategy, qualification data, smoke studies, and interventions. Define alert and action levels, organism identification, disinfectant rotation, sporicide use, investigation triggers, and batch-impact assessment before production. Annex 1 also expects trend review and documented responses when limits are exceeded.
Good cleanroom construction cannot compensate for weak behavior or maintenance. Non-sterile facilities and a pharmacy clean room need proportionate controls, while modular cleanrooms still require calibrated instruments, documented cleaning, trend review, and change management.
We'll call you
In order to serve you better, if you could kindly send an e-mail to nick@biogreenness.com for questions and details about your theoretical and special architectural plans, projects, and product specifications, your request will be responded to as soon as possible.
We'll call you
In order to serve you better, if you could kindly send an e-mail to nick@biogreenness.com for questions and details.
